ADRA2A promotes the classical/progenitor subtype and reduces disease aggressiveness of pancreatic cancer.
Moreno P, Ohara Y, Craig AJ, Liu H, Yang S, Dorsey TH, Zhang L, Panigrahi G, Cawley H, Azizian A, Gaedcke J, Ghadimi M, Hanna N, Hussain SP.
Moreno P, et al. Among authors: craig aj.
Carcinogenesis. 2024 Nov 22;45(11):845-856. doi: 10.1093/carcin/bgae056.
Carcinogenesis. 2024.
PMID: 39136088